Geraniol and geranyl acetate induce potent anticancer effects in colon cancer Colo-205 cells by inducing apoptosis, DNA damage and cell cycle arrest

Purpose: Colon Cancer ranks second in mortality among all human malignancies, creating thus a need for exploration of novel molecules that would prove effective, cost-effective and with lower toxicity. In the recent past monoterpenes have gained tremendous attention for their Anticancer activity. In the present study we evaluated the Anticancer effects of two important monoterpenes, geraniol and geranyl acetate against colo-205 Cancer cells.

Methods: The antiproliferative activity was determined by MTT assay. Apoptosis was assessed by DAPI staining and DNA damage was checked by comet assay. The cell cycle analysis was carried out by flow cytometry and protein expression was examined by western blotting.

Results: The results showed that both geraniol and geranyl acetate exhibited significant Anticancer activity against colo-205 Cancer cell line with IC50 values of 20 and 30 μM respectively. To find out the underlying mechanism, DAPI staining was carried out and it was observed that both the monoterpenes, geraniol and geranyl acetate, induced Apoptosis in colo-205 cells. The Apoptosis was also associated with upregulation of Bax and downregulation of Bcl-2 expressions, indicative of mitochondrial Apoptosis. Moreover, these two monoterpenes could trigger DNA damage and G2/M cell cycle arrest in colo-205 cells.

Conclusions: Taken together, we propose that geraniol and geranyl acetate may prove to be important lead molecular candidates for the treatment of colon Cancer. Their Anticancer activity can be attributed to the ability to trigger Apoptosis, DNA damage and cell cycle arrest.